SAM CHUN DANG PHARM CO. LTD
000250 | KO
Overview
Corporate Details
- ISIN(s):
- KR7000250001
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약공단2길 71, 화성시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-19 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(교환사채권발행결정)
|
Korean | 30.5 KB | ||
| 2025-09-19 00:00 |
Transaction in Own Shares
[기재정정]주요사항보고서(자기주식처분결정)
|
Korean | 40.4 KB | ||
| 2025-09-19 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 22.0 KB | ||
| 2025-09-19 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 7.4 KB | ||
| 2025-08-27 00:00 |
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
|
Korean | 25.0 KB | ||
| 2025-08-27 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 32.5 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 2.2 MB | ||
| 2025-07-30 00:00 |
AGM Information
임시주주총회결과
|
Korean | 9.2 KB | ||
| 2025-07-24 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 100.9 KB | ||
| 2025-07-24 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.2 KB | ||
| 2025-07-24 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-07-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 61.1 KB | ||
| 2025-06-30 00:00 |
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결(자율공시)
|
Korean | 19.9 KB | ||
| 2025-06-24 00:00 |
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 41.3 KB | ||
| 2025-06-24 00:00 |
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 41.2 KB |
Automate Your Workflow. Get a real-time feed of all SAM CHUN DANG PHARM CO. LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for SAM CHUN DANG PHARM CO. LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAM CHUN DANG PHARM CO. LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.
South Korea
226950
South Korea
226950
Develops first-in-class therapeutics for challenging diseases with unmet medical needs.
United States of America
OMER
United States of America
OMER
Develops precision therapies & diagnostics for resistant and metastatic cancers.
France
ALOPM
France
ALOPM
Developing alpha-emitting radiotherapies for treating cancers in the peritoneal cavity.
Norway
OCIN
Norway
OCIN
Developing oncolytic virus therapies and diagnostics for cancer and serious viral infections.
Japan
4588
Japan
4588
Developing an immuno-oncolytic virus to treat breast and gastrointestinal cancers.
United States of America
ONCY
United States of America
ONCY
Develops diagnostics and therapeutics for men's health and oncology markets.
United States of America
ONCO
United States of America
ONCO
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
South Korea
476060
Develops targeted therapies for hematological cancers using peptide-drug conjugate technology.
Sweden
ONCO
Sweden
ONCO
Sweden
ONCOZ